Skip to main content
TipRanks
Go Ultimate75% OFF

Inhibikase Therapeutics (IQT0) Market Cap & Net Worth

1 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of EUR 185.03M as of Nov 18, 2026. Its market cap has increase by 55.19% in one year.

Market Cap
EUR 185.03M
Enterprise Value
EUR 211.39M
1-Year Change
55.19%
Category
Micro (Under 300M)
Stock Price
EUR 2.5

Market Cap Chart

0.00100.00M200.00M300.00M400.00MNov 21Nov 22Nov 23Nov 24Nov 25
Market Cap History
Download to Excel
DE:IQT0 market cap history
DateMarket Cap% Change
Nov 16, 2026203.39M-4.61%
Nov 13, 2026213.21M-0.65%
Nov 12, 2026214.61M-5.64%
Nov 11, 2026227.44M+5.16%
Nov 10, 2026216.28M-7.74%
Nov 09, 2026234.42M+12.00%
Nov 06, 2026209.30M+4.17%
Nov 05, 2026200.93M-7.99%
Nov 04, 2026218.37M+5.74%
Nov 03, 2026206.51M-3.90%
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Related stocks
CompanyMarket Cap
DE:IQT0EUR 185.03M
ATOS$19.26M
ANIX$88.65M
SPRO$55.14M
SRZN$616.07M
TCRX$9.83M